AbbVie (ABBV) FCF Payout Ratio (2013 - 2026)

AbbVie (ABBV) reported FCF Payout Ratio of 0.87 for Q1 2026, down 58.56% year-over-year from 2.09 in Q1 2025, and up 45.42% quarter-over-quarter from 0.6 in Q4 2025.

AbbVie (ABBV) FCF Payout Ratio (2013 - 2026) Analysis & Trends

AbbVie (ABBV) has 14 years of FCF Payout Ratio data on file, last reported at 0.87 in Q1 2026.

  • FCF Payout Ratio for Q1 2026 came in at 0.87, down 58.56% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.59 (down 18.59% YoY), and the FY2025 annual result was 0.65, up 5.83% from the prior year.
  • FCF Payout Ratio improved to 0.87 in Q1 2026 per ABBV's latest filing, from 0.6 in the prior quarter.
  • Over five years, FCF Payout Ratio peaked at 2.09 in Q1 2025 and troughed at 0.34 in Q3 2022.
  • A 5-year average of 0.67 and a median of 0.53 in 2022 frame the typical range for FCF Payout Ratio.
  • The sharpest annual moves came in 2024 and 2026: FCF Payout Ratio surged 216.92% in 2024, then slumped 58.56% in 2026.
  • A 5-year view of FCF Payout Ratio shows it stood at 0.35 in 2022, then jumped by 66.24% to 0.58 in 2023, then dropped by 29.46% to 0.41 in 2024, then soared by 46.19% to 0.6 in 2025, then jumped by 45.42% to 0.87 in 2026.
  • Business Quant data shows ABBV's FCF Payout Ratio at 0.87 in Q1 2026, 0.6 in Q4 2025, and 0.44 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Cover (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn -0.41
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn 0.51
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 2.14
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn 0.87
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn 0.72
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn 0.92
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn 0.43
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn 1.12
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn 1.69
10 Novartis Ag 108.28 Bn 107.60 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 0.87
Dec 31, 2025 0.60
Sep 30, 2025 0.44
Jun 30, 2025 0.60
Mar 31, 2025 2.09
Dec 31, 2024 0.41
Sep 30, 2024 0.53
Jun 30, 2024 1.35
Mar 31, 2024 0.72
Dec 31, 2023 0.58
Sep 30, 2023 0.36
Jun 30, 2023 0.43
Mar 31, 2023 0.66
Dec 31, 2022 0.35
Sep 30, 2022 0.34
Jun 30, 2022 0.52
Mar 31, 2022 0.53
Dec 31, 2021 0.47
Sep 30, 2021 0.30
Jun 30, 2021 0.49